Compositions and methods of enhancing immune responses to enteric pathogens
US10376571B2 · kind B2 · utility
1Cited by
24References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Aug 13, 2019 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be expressed on the surface of the vaccine vector. The vaccine vector may also include a second polypeptide encoding an immunostimulatory polypeptide such as a CD154 polypeptide or an HMGB1 polypeptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.